RecruitingPhase 2NCT05077280

A Study of Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal Melanoma

Studying Uveal melanoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
California Pacific Medical Center Research Institute
Principal Investigator
David R Minor, MD
California Pacific Med Center Research Inst.
Intervention
stereotactic body radiotherapy(radiation)
Enrollment
40 target
Eligibility
18 years · All sexes
Timeline
2021 – 2026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05077280 on ClinicalTrials.gov

Other trials for Uveal melanoma

Additional recruiting or active studies for the same condition.

See all trials for Uveal melanoma →

← Back to all trials